Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
125,886,121
-
Share change
-
-2,047,941
-
Total reported value
-
$395,283,383
-
Put/Call ratio
-
274%
-
Price per share
-
$3.14
-
Number of holders
-
191
-
Value change
-
-$6,540,600
-
Number of buys
-
90
-
Number of sells
-
71
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q2 2016
As of 30 Jun 2016,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
125,886,121 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., MACKENZIE FINANCIAL CORP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Bank of New York Mellon Corp, and Emerald Acquisition Ltd..
This page lists
191
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.